Nalaganje...
Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease
While hydroxycarbamide (hydroxyurea, HU) has less and fewer indications in malignant hemopathies, it represents the only widely used drug which modifies sickle cell disease pathogenesis. Clinical experience with HU for patients with sickle cell disease has been accumulated over the past 25 years in...
Shranjeno v:
| izdano v: | Mediterr J Hematol Infect Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Università Cattolica del Sacro Cuore
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5333733/ https://ncbi.nlm.nih.gov/pubmed/28293403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.015 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|